Logo

semiconductor

Atantares Closes Early Financing Rounds, Raising RMB 100M

The Beijing-based firm is developing semiconductor chips for use in biotechnology, including high-throughput DNA synthesis.

Roswell Biotechnologies, IMEC Partner on Biosensor Chips

The firms have already completed proof-of-concept studies for their semiconductor biosensor chips and Roswell plans to have the initial chips by 2021.

Following Financial Restructuring, Nabsys Resurfaces With Much of Original Leadership Team

After closing its doors last September, Nabsys has resumed operations, refocusing on its core technology.

Fox Chase Debuts CancerCode-45 Test Based on Adapted Ion Torrent AmpliSeq Panel
Premium

The Fox Chase Cancer Center has begun offering targeted sequencing to inform cancer treatment using an adaptation of Life Technologies' Ion Torrent AmpliSeq Cancer Panel via its CLIA-certified laboratory.

DNAe Plans Pilot Trials of Handheld Semiconductor DNA Testing Platform for PGx, Infectious Disease
Premium

By Ben Butkus DNA Electronics will begin pre-clinical pilot trials later this year to prepare its rapid, handheld, semiconductor-based DNA testing platform for clinical diagnostic use, the company said this week.
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.